2-Nitrophenol
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
139.11 2 1 1.82 nt1589 None Not checked

SMILES: Oc1ccccc1[N+]([O-])=O

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[2-Nitrophenol] 2.16 25.0 Kenneth A. Connors 1995

2-Nitrophenol anion
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
138.10 1 0 2.26 nt0671 None Not checked

SMILES: C1=CC=C(C(=C1)[N+](=O)[O-])[O-]

Supramolecules

Namelog KSDpHT(°C)MethodRef
[a-Cyclodextrin](1).[2-Nitrophenol anion] 2.30 25.0 Kenneth A. Connors 1995

2-Nitrophenol anion
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
138.10 1 0 2.26 nt1591 None Not checked

SMILES: C1=CC=C(C(=C1)[N+](=O)[O-])[O-]

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[2-Nitrophenol anion] 2.00 25.0 Kenneth A. Connors 1995

2-O-(2-Hydroxy)propyl-a-Cyclodextrin
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
None None CY-1005.0 None

SMILES:

Supramolecules

Namelog KSDpHT(°C)MethodRef
[2-O-(2-Hydroxy)propyl-a-Cyclodextrin](1).[cyclosporin A] 2.94 7.0 25.0 HPLC method Laura Matilainen 2006
[2-O-(2-Hydroxy)propyl-a-Cyclodextrin](1).[heptane] 2.30 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-a-Cyclodextrin](1).[benzyl alcohol] 0.60 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-a-Cyclodextrin](1).[nimodipine] 1.99 1.00 7.0 25.0 UV-vis spectroscopy Frantisek Kopecky 2001
[2-O-(2-Hydroxy)propyl-a-Cyclodextrin](1).[triclosan] 3.54 7.0 25.0 UV-vis spectroscopy P. Mura 2005
[2-O-(2-Hydroxy)propyl-a-Cyclodextrin](1).[4-nitrophenolate] 3.27 1.96 11.1 27.8 Capillary electrophoresis David M. Goodall 1995

2-O-(2-Hydroxy)propyl-b-Cyclodextrin
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
None None CY-2005.0 None

SMILES:

Supramolecules

Namelog KSDpHT(°C)MethodRef
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.46 7.2 15.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.38 7.2 20.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.30 7.2 25.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.26 7.5 25.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.23 7.2 30.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-benzoyl-1H-benzimidazol-2-yl-carbamic acide methyl ester] 3.10 7.2 40.0 Higuchi and Connors solubility method Shehatta, Ibrahim 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin].[7-methoxycoumarin] 2.08 1.30 fluorescence suppression Wagner, Brian D. 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[caffeine] 2.44 1.58 25.0 fluorescence spectroscopy Aicart, Emilio 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[acyclovir] 2.88 2.20 25.0 fluorescence spectroscopy Aicart, Emilio 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[triclosan] 4.00 phase solubility Loftsson, Thorsteinn 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[triclosan] 2.38 10.0 phase solubility Loftsson, Thorsteinn 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[triclosan] 3.91 4.6 37.0 UV-vis spectroscopy Maria José Alonso 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[triclosan] 3.91 7.0 25.0 UV-vis spectroscopy P. Mura 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine] 2.47 0.85 25.0 phase solubility Cappello, Brunella 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[diphenhydramine] 3.21 23.0 phase solubility Pascal Le Corre 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[diphenhydramine] 2.69 37.0 phase solubility Pascal Le Corre 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Progesterone] 4.98 7.4 10.0 phase solubility B. Luppi 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Progesterone] 4.04 7.4 25.0 phase solubility B. Luppi 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Progesterone] 3.85 7.4 37.0 phase solubility B. Luppi 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Ebselen] 2.90 7.0 25.0 phase solubility Kaneto Uekama 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Cyproterone acetate] 3.80 25.0 phase solubility Sandrine Henry De Hassonville 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[fentanyl] 1.86 6.5 phase solubility J. Plaizier-Vercammen 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[fentanyl] 2.03 7.2 phase solubility J. Plaizier-Vercammen 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[fentanyl] 2.90 8.0 phase solubility J. Plaizier-Vercammen 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[13-cis-retinoic acid] 1.71 5.9 phase solubility P.C. Ho 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[13-cis-retinoic acid] 4.13 7.4 phase solubility P.C. Ho 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[13-cis-retinoic acid] 3.91 8.1 phase solubility P.C. Ho 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[13-cis-retinoic acid] 2.71 5.9 phase solubility P.C. Ho 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[benzene] 2.14 25.0 modified static head-space gas chromatography method (M-SHSGC) Yoshihiro Saito 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[benzene] 2.00 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[toluene] 2.26 25.0 modified static head-space gas chromatography method (M-SHSGC) Yoshihiro Saito 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[toluene] 2.16 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[toluene] 2.23 1.11 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-Xylene] 2.42 25.0 modified static head-space gas chromatography method (M-SHSGC) Yoshihiro Saito 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-Xylene] 1.34 25.0 modified static head-space gas chromatography method (M-SHSGC) Yoshihiro Saito 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-Xylene] 2.51 25.0 modified static head-space gas chromatography method (M-SHSGC) Yoshihiro Saito 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2',3'-dideoxyadenosine] 1.75 0.43 4.0 UV spectrophotometry Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2',3'-dideoxyadenosine] 1.68 0.41 25.0 UV spectrophotometry Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2',3'-dideoxyadenosine] 1.56 0.30 37.0 UV spectrophotometry Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2',3'-dideoxyadenosine] 1.44 0.20 50.0 UV spectrophotometry Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[spironolactone] 4.20 phase solubility Kaneto Uekama 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[spironolactone] 4.04 2.0 25.0 HPLC-method Valentino J. Stella 2000
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[papaverine] 1.89 7.4 37.0 Higuchi and Connors method G. Puglisi 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[glycyrrhetinic acid] 2.06 1.15 7.0 Higuchi and Connors method Noelle Martine Gosselet 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[glycyrrhetinic acid] 0.53 -0.30 7.0 Higuchi and Connors method Noelle Martine Gosselet 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Parsol MCX] 2.36 1.54 7.0 Higuchi and Connors method Noelle Martine Gosselet 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[Parsol MCX] 2.30 1.48 7.0 Higuchi and Connors method Noelle Martine Gosselet 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[levomenthol] 2.29 1.46 7.0 Higuchi and Connors method Noelle Martine Gosselet 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Cholesterol] 4.26 25.0 Potential of mean force Wensheng Cai 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[propranolol] 2.08 1.48 7.0 25.0 Calorimetry Giuseppina Castronuovo 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Methyl orange] 3.73 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Eugenol] 2.65 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Isoeugenol] 2.66 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Benzyl alcohol] 1.73 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Anisyl alcohol] 2.19 5.8 25.0 UV-Vis spectroscopy Sophie Fourmentin 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hydrocortisone] -3.20 7.4 30.0 HPLC-method Nigel M. Davies 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.07 5.0 70.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.30 5.0 60.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.19 5.0 50.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.38 5.0 37.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.36 7.4 70.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.17 7.4 60.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.10 7.4 50.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dipivefrine] 3.22 7.4 37.0 HPLC-method Pekka Jarho 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.29 2.30 15.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.21 2.20 20.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.16 2.15 25.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.11 2.11 30.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.97 1.95 40.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.16 2.18 26.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.16 2.18 27.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.14 2.15 28.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.19 2.20 29.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.15 2.15 36.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.20 2.20 37.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.18 2.18 38.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.19 2.20 42.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.18 2.18 43.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.16 2.11 44.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 3.16 2.11 45.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.62 1.60 31.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.63 1.60 32.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.64 1.60 33.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.72 1.70 34.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.74 1.78 35.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.62 1.60 39.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.59 1.60 41.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.75 1.78 46.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.74 1.78 47.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.69 1.70 48.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprophen] 2.73 1.70 49.0 Potentiometric measurements E. Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenylbutazone] 3.34 2.30 15.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenylbutazone] 3.28 2.30 20.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenylbutazone] 3.26 2.30 25.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenylbutazone] 3.21 0.78 30.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenylbutazone] 3.15 2.30 37.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 2.85 2.00 7.5 15.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 2.78 1.60 7.5 20.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 2.78 2.00 7.5 25.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 2.72 1.90 7.5 30.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 2.66 1.78 7.5 37.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 2.95 2.00 15.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 3.00 2.30 20.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 2.90 2.00 25.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 3.08 2.30 30.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[oxyphenbutazone] 3.04 2.48 37.0 UV-vis spectroscopy David Diaz 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[neutral red] 2.08 5.0 20.0 Fluorescence spectroscopy Shaomin Shuang 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[neutral red] 3.00 7.5 20.0 Fluorescence spectroscopy Shaomin Shuang 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[neutral red] 3.13 10.5 20.0 Fluorescence spectroscopy Shaomin Shuang 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2,4-dichlorophenoxyacetic acid] 1.80 5.0 25.0 Fluorescence spectroscopy J. M. Bosque-Sendra 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2,4-dichlorophenoxyacetic acid] 1.99 7.0 25.0 UV-vis spectroscopy Jose I. Perez-Martinez 2000
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[8-methoxypsoralen] 1.47 5.0 HPLC-method Yves Guillaume 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[8-methoxypsoralen] 1.27 25.0 HPLC-method Yves Guillaume 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[Chlorophyll a] 1.18 0.30 7.0 Fluorescence spectroscopy Lucia Catucci 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[((5-chloro-N-2-chloro-4-nitrophenyl)-2-hydroxybenzamide] 1.30 6.5 30.0 HPLC-method Melgardt M. de Villiers 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](0.5).[((5-chloro-N-2-chloro-4-nitrophenyl)-2-hydroxybenzamide] 2.53 6.5 30.0 HPLC-method Melgardt M. de Villiers 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Ro 28-2653] 4.10 7.0 37.0 HPLC-method Bertholet Pascal 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[Ro 28-2653] 1.16 7.0 37.0 HPLC-method Bertholet Pascal 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[risperidone] 3.35 10.5 25.0 UV-Vis spectroscopy M.B. Zughul 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[risperidone] 1.34 10.5 25.0 UV-Vis spectroscopy M.B. Zughul 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-norpregn-4-ene-3,20-dione] 3.45 2.44 7.4 30.0 UV-vis spectroscopy Sayed M. Ahmed 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-norpregn-4-ene-3,20-dione] 3.36 2.18 7.4 37.0 UV-vis spectroscopy Sayed M. Ahmed 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-norpregn-4-ene-3,20-dione] 3.05 1.56 7.4 45.0 UV-vis spectroscopy Sayed M. Ahmed 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[1 -anilinonaphthalene-8-sulfonate] 2.63 1.85 6.8 Fluorescence spectroscopy Brian D. Wagner 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[chlorambucil] 3.53 2.86 7.35 40.0 HPLC-method Thorsteinn Loftsson 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[chlorambucil] 3.58 1.95 7.5 30.0 HPLC-method Thorsteinn Loftsson 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[indomethacin] 2.84 1.78 9.8 40.0 HPLC-method Thorsteinn Loftsson 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[indomethacin] 2.84 1.78 10.0 40.0 HPLC-method Thorsteinn Loftsson 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[indomethacin] 2.85 9.0 30.0 NMR spectroscopy Gregory Gregoriadis 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[indomethacin] 2.98 9.0 30.0 UV-vis spectroscopy Gregory Gregoriadis 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[diazepam] 2.08 1.00 2.0 30.5 HPLC-method Thorsteinn Loftsson 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[rose bengal] 2.15 1.48 7.0 25.0 UV-Vis spectroscopy P. Fini 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[rose bengal] 2.11 1.30 7.0 25.0 Calorimetry P. Fini 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Carbon tetrachloride] 2.34 7.0 30.0 Solubility method, titration method Sophie Fourmentin 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Toluene] 2.21 7.0 30.0 Solubility method, titration method Sophie Fourmentin 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[niclosamide] 1.30 7.0 30.0 HPLC-method Melgardt M. de Villiers 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](0.5).[niclosamide] 2.53 7.0 30.0 HPLC-method Melgardt M. de Villiers 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Fe(III)-tetrakis(sulfonatophenyl)porphyrin] 3.59 0.02 6.0 25.0 UV-Vis spectroscopy Masami Fukushima 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[naproxen] 3.32 7.0 25.0 UV-vis spectroscopy Paola Mura 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[naproxen] 3.24 7.0 37.0 UV-vis spectroscopy Paola Mura 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[naproxen] 3.23 7.0 45.0 UV-vis spectroscopy Paola Mura 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[tetrakis(sulfonatophenyl)porphyrin] 3.27 0.03 6.0 25.0 UV-Vis spectroscopy Masami Fukushima 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[human growth hormone] 2.34 2.5 25.0 Fluorescence spectroscopy Daniel Erik Otzen 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[skatol] 2.26 1.00 7.0 25.0 UV-vis spectroscopy, fluorescence spectroscopy Alicia V. Veglia 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[auxin] 2.15 1.48 7.0 25.0 UV-vis spectroscopy, fluorescence spectroscopy Alicia V. Veglia 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[auxin] 2.30 1.60 3.0 25.0 UV-vis spectroscopy, fluorescence spectroscopy Alicia V. Veglia 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprofen] 4.06 2.48 3.2 25.0 Calorimetry Annette Bauer-Brandl 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprofen] 4.04 2.60 3.95 25.0 Calorimetry Annette Bauer-Brandl 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprofen] 3.86 2.48 5.0 25.0 Calorimetry Annette Bauer-Brandl 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprofen] 3.65 2.48 6.2 25.0 Calorimetry Annette Bauer-Brandl 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprofen] 3.60 2.48 7.0 25.0 Calorimetry Annette Bauer-Brandl 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprofen] 3.60 2.48 8.0 25.0 Calorimetry Annette Bauer-Brandl 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprofen] 3.52 2.60 8.2 25.0 Calorimetry Annette Bauer-Brandl 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dodecyltrimethylammonium chloride] 3.98 2.30 7.0 25.0 Fluorescence spectroscopy Catherine Amiel 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ascorbic acid] 0.61 -0.52 7.0 25.0 Calorimetry I. V. Terekhova 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ascorbic acid] 0.70 -0.54 2.0 20.0 UV-vis spectroscopy Irina V. Terekhova 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ascorbic acid] 0.63 -0.39 2.0 25.0 Calorimetry Irina V. Terekhova 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hesperidin] 1.78 1.30 7.0 25.0 Fluorescence spectroscopy M.L. Calabro 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hesperidin] 1.95 1.48 7.0 25.0 UV-vis spectroscopy M.L. Calabro 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hesperetin] 4.28 3.60 7.0 25.0 Fluorescence spectroscopy M.L. Calabro 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hesperetin] 4.32 3.60 7.0 25.0 UV-vis spectroscopy M.L. Calabro 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[zinc diethyldithiocarbamate] 3.54 7.0 25.0 HPLC-method Siling Wang 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[sodium perfluoroctanoate] 3.38 2.78 7.0 25.0 Conductivity measurements Emilio Aicart 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dexamethasone] 3.34 1.34 7.0 25.0 Phase solubility studies Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dexamethasone] 3.35 2.07 7.0 25.0 UV-vis spectroscopy Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dexamethasone acetate] 3.35 2.05 6.0 25.0 Phase solubility studies Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dexamethasone acetate] 3.39 2.06 6.0 25.0 UV-vis spectroscopy Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dexamethasone acetate] 3.36 1.94 7.0 25.0 Kinetic measurements Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[dexamethasone acetate] 0.48 6.0 25.0 Phase solubility studies Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[dexamethasone acetate] 1.23 0.90 6.0 25.0 UV-vis spectroscopy Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[dexamethasone acetate] 1.30 0.48 7.0 25.0 Kinetic measurements Milind M. Narurkar 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] 5.90 5.15 Fluorescence spectroscopy Athena Kasselouri 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[5,10,15,20-tetra(m-hydroxyphenyl)chlorin] 9.43 8.00 Fluorescence spectroscopy Athena Kasselouri 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[O,O'-dipivalyl(1,4-xylylene) bispilocarpic acid diester] 2.91 7.4 25.0 HPLC-method Pekka Jarho 1995
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[O,O'-dipivalyl(1,4-xylylene) bispilocarpic acid diester] 2.92 7.4 25.0 HPLC-method Pekka Jarho 1995
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[O,O'-dicyclobutanecarbonyl(1,2-ethylene) bispilocarpic acid diester] 2.16 7.4 25.0 HPLC-method Pekka Jarho 1995
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[O,O'-dicyclobutanecarbonyl(1,2-ethylene) bispilocarpic acid diester] 1.46 7.4 25.0 HPLC-method Pekka Jarho 1995
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[anetholetrithione] 3.79 7.0 37.0 HPLC-method Gilles Dollo 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-phenyldithiolethione] 3.46 7.0 37.0 HPLC-method Gilles Dollo 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dimethyldithiolethione] 2.82 7.0 37.0 HPLC-method Gilles Dollo 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dithiolethione] 2.35 7.0 37.0 HPLC-method Gilles Dollo 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dithiolethione] 2.25 7.0 37.0 UV-vis spectroscopy Gilles Dollo 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Pindolol] 1.76 0.48 12.0 25.0 HPLC-method Arantza Zornoza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hydrocortisone butyrate ] 3.92 4.0 20.0 Solubility method (UV-vis spectroscopy) In Koo Chun 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hydrocortisone butyrate ] 3.79 4.0 30.0 Solubility method (UV-vis spectroscopy) In Koo Chun 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hydrocortisone butyrate ] 3.72 4.0 37.0 Solubility method (UV-vis spectroscopy) In Koo Chun 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hydrocortisone butyrate ] 3.78 4.0 25.0 Circular dichroism spectroscopy In Koo Chun 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hydrocortisone butyrate ] 3.68 4.0 25.0 UV-vis spectroscopy In Koo Chun 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[warfarin] 2.65 1.26 7.4 37.0 Fluorescence spectroscopy Serdar Ates 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-nitrophenol] 2.73 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-nitrophenol] 2.34 7.0 25.0 HPLC-method Michel Morcellet 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[L-Phe ] 0.70 -0.30 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Gly-L-Phe ] 1.15 -0.10 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Gly-D-Phe ] 1.11 -0.30 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[L-PheGly ] 1.34 0.30 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[GlyGly-L-Phe ] 1.32 0.08 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Gly-L-Tyr ] 1.20 -0.05 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[L-TrpGly ] 1.70 0.58 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Aspartame] 1.87 0.66 7.4 23.0 UV-vis spectroscopy Jiri Horsky 1994
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Adenine ] 1.02 0.15 7.0 25.0 UV-vis spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Adenosine] 1.10 0.18 7.0 25.0 UV-vis spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2’-Deoxyadenosine] 1.52 0.79 7.0 25.0 UV-vis spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5’-Deoxyadenosine ] 1.35 0.36 7.0 25.0 Circular dichroism spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2’,3’-Dideoxyadenosine ] 1.49 0.79 7.0 25.0 Circular dichroism spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2’,3’-Dideoxyadenosine ] 1.68 0.41 7.0 25.0 UV-vis spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2’,3’-Dideoxyadenosine] 1.09 -0.40 7.0 25.0 UV-vis spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[adenine arabinoside] 1.70 0.91 7.0 25.0 UV-vis spectroscopy Bradley D. Anderson 1990
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[acitretin] 3.64 2.69 7.4 25.0 HPLC-method Paul C. Ho 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[acitretin] 1.94 0.95 9.0 25.0 HPLC-method Paul C. Ho 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate] 2.92 1.96 4.0 15.0 Circular dichroism spectroscopy Kaneto Uekama 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate] 2.87 1.60 4.0 25.0 Circular dichroism spectroscopy Kaneto Uekama 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate] 2.80 1.78 4.0 30.0 Circular dichroism spectroscopy Kaneto Uekama 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate] 2.78 1.92 4.0 37.0 Circular dichroism spectroscopy Kaneto Uekama 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Artemisinin ] 2.68 7.4 28.0 HPLC-method Christy M. Wyandt 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Dihydroartemisinin] 2.61 7.4 28.0 HPLC-method Christy M. Wyandt 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Artether ] 2.51 7.4 28.0 HPLC-method Christy M. Wyandt 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[10-deoxoartemisinin] 2.16 7.4 28.0 HPLC-method Christy M. Wyandt 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid methyl ester] 2.99 7.4 25.0 HPLC-method B.W. Müller 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid ethyl ester] 2.98 7.4 25.0 HPLC-method B.W. Müller 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid propyl ester] 3.19 7.4 25.0 HPLC-method B.W. Müller 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid butyl ester] 3.53 7.4 25.0 HPLC-method B.W. Müller 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid amyl ester] 3.68 7.4 25.0 HPLC-method B.W. Müller 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid benzyl ester] 3.78 7.4 25.0 HPLC-method B.W. Müller 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Diphenidol HCl] 2.20 0.85 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Diphenhydramine HCI] 2.39 1.21 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Orphenadrine HCI ] 2.38 0.60 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Bromodiphenhydramine HCl ] 2.74 1.56 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Diphenylpyraline HCI ] 2.55 1.27 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Cyclizine HCl] 2.42 1.17 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Chlorcyclizine HCI] 2.63 1.65 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Chlorcyclizine 2HCl] 2.61 1.83 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Meclizine 2HCl] 2.54 1.35 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Hydroxyzine HCI] 2.59 1.18 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Hydroxyzine 2HCl ] 2.58 1.54 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Proadifen HCl] 2.74 0.36 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Adiphenine HCl ] 2.81 1.63 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Terfenadine HCl] 4.49 3.29 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[Terfenadine HCl] 2.68 1.58 7.0 25.0 Calorimetry J. Keith Guillory 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Barbituric acid] 3.94 5.5 25.0 Calorimetry Hatsumi Aki 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Barbital] 3.97 5.5 25.0 Calorimetry Hatsumi Aki 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Amobarbital ] 4.21 5.5 25.0 Calorimetry Hatsumi Aki 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Pentobarbital ] 4.32 5.5 25.0 Calorimetry Hatsumi Aki 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Secobarbital ] 4.62 5.5 25.0 Calorimetry Hatsumi Aki 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Cyclobarbital ] 4.78 5.5 25.0 Calorimetry Hatsumi Aki 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Phenobarbital] 4.86 5.5 25.0 Calorimetry Hatsumi Aki 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Ad-PEG-COOH] 3.65 2.77 7.0 HPLC-method M. C. Millot 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Ad-PEG-OCH3] 3.72 2.83 7.0 HPLC-method M. C. Millot 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[[[1,4-dihydro-1-methyl-3-pyridinyl)carbonyl]-methyl[2S-(2a, 5a, 6b,)]-3,3-dimethyl-7-oxo-7-[(phenylacetyl)amino]-4-thia-azabicyclo[3.2.0] heptane-2-carboxylate] 2.97 4.66 40.0 HPLC-method Emil Pop 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[[[1,4-dihydro-1-methyl-3-pyridinyl)carbonyl]-methyl[2S-(2a, 5a, 6b,)]-3,3-dimethyl-7-oxo-7-[(phenylacetyl)amino]-4-thia-azabicyclo[3.2.0] heptane-2-carboxylate] 2.86 6.87 40.0 HPLC-method Emil Pop 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[[[1,4-dihydro-1-methyl-3-pyridinyl)carbonyl]-methyl[2S-(2a, 5a, 6b,)]-3,3-dimethyl-7-oxo-7-[(phenylacetyl)amino]-4-thia-azabicyclo[3.2.0] heptane-2-carboxylate] 2.89 8.36 40.0 HPLC-method Emil Pop 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[[[1,4-dihydro-1-methyl-3-pyridinyl)carbonyl]-methyl[2S-(2a, 5a, 6b,)]-3,3-dimethyl-7-oxo-7-[(phenylacetyl)amino]-4-thia-azabicyclo[3.2.0] heptane-2-carboxylate] 2.90 8.91 40.0 HPLC-method Emil Pop 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[[[1,4-dihydro-1-methyl-3-pyridinyl)carbonyl]-methyl[2S-(2a, 5a, 6b,)]-3,3-dimethyl-7-oxo-7-[(phenylacetyl)amino]-4-thia-azabicyclo[3.2.0] heptane-2-carboxylate] 2.91 6.45 70.0 HPLC-method Emil Pop 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[[[1,4-dihydro-1-methyl-3-pyridinyl)carbonyl]-methyl[2S-(2a, 5a, 6b,)]-3,3-dimethyl-7-oxo-7-[(phenylacetyl)amino]-4-thia-azabicyclo[3.2.0] heptane-2-carboxylate] 2.48 6.45 62.1 HPLC-method Emil Pop 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[[[1,4-dihydro-1-methyl-3-pyridinyl)carbonyl]-methyl[2S-(2a, 5a, 6b,)]-3,3-dimethyl-7-oxo-7-[(phenylacetyl)amino]-4-thia-azabicyclo[3.2.0] heptane-2-carboxylate] 2.26 6.45 51.5 HPLC-method Emil Pop 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[thiazolobenzimidazole] 1.91 2.0 25.0 HPLC-method Bradley D. Anderson 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[thiazolobenzimidazole] 3.01 7.0 25.0 HPLC-method Bradley D. Anderson 1993
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[fenoprofen calcium dihydrate] 2.85 1.62 7.4 25.0 UV-vis spectroscopy David Diaz 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[fenoprofen calcium dihydrate] 3.08 2.02 7.4 25.0 Fluorescence spectroscopy David Diaz 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprofen ] 4.10 7.0 25.0 UV-vis spectroscopy Henderik W. Frijlink 1991
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ampicillin] 4.01 3.00 1.2 25.0 Microcalorimetry Hatsumi Aki 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ampicillin] 3.76 2.60 2.0 25.0 Microcalorimetry Hatsumi Aki 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ampicillin] 3.11 2.30 4.2 25.0 Microcalorimetry Hatsumi Aki 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ampicillin] 3.26 2.70 6.0 25.0 Microcalorimetry Hatsumi Aki 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ampicillin] 2.81 2.00 8.0 25.0 Microcalorimetry Hatsumi Aki 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-chlorophenyl hydrogen maleate] 2.15 1.20 2.0 25.0 UV/VIS spectrometry Rita H. de Rossi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-chlorophenyl hydrogen maleate] 2.00 0.90 2.0 25.0 UV/VIS spectrometry Rita H. de Rossi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-methylphenyl hydrogen maleate] 1.82 1.34 2.0 25.0 UV/VIS spectrometry Rita H. de Rossi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-methylphenyl hydrogen maleate] 1.91 1.15 2.0 25.0 UV/VIS spectrometry Rita H. de Rossi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenyl hydrogen maleate] 2.02 1.48 2.0 25.0 UV/VIS spectrometry Rita H. de Rossi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[rofecoxib] 2.29 7.0 30.0 UV/VIS spectrometry Sanjula Baboota, 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[naphtalene] 2.79 7.0 22.0 UV/VIS spectrometry Khalil Hanna 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[butyric acid] 1.66 0.61 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[isobutyric acid] 1.52 0.59 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[valeric acid] 2.00 0.77 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[isovaleric acid] 2.16 1.20 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[succinic acid] 0.63 0.11 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cadaverine] 1.21 -0.70 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenantrene] 3.44 7.0 22.0 UV/VIS spectrometry Khalil Hanna 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[putrescine] 0.81 -0.05 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[pyridine ] 1.41 0.49 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-methyl-pyridine] 1.45 0.51 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[diphenylamine] 2.40 1.21 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hydrogen sulfide] 0.80 -0.32 22.0 HS-GCMS Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[methanethiol] 0.28 -0.92 22.0 HS-GCMS Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dimethyl sulfide] 0.64 -0.92 22.0 HS-GCMS Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenyl acetate] 2.05 0.86 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-cresol] 2.12 1.14 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-cresol] 2.25 7.0 25.0 HPLC-method Michel Morcellet 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenol ] 1.72 0.75 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[indole] 2.14 0.93 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[skatole] 2.24 0.84 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dodecanol] 2.20 1.16 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[tatradecanol] 2.02 0.84 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[prazosin hydrochloride] 1.32 0.46 7.0 25.0 UV-vis spectroscopy Longxiao Liu 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[furosemide] 3.22 4.6 37.0 UV-vis spectroscopy Maria José Alonso 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[methyl orange] 2.28 5.0 25.0 UV electronic spectroscopy O. A. C. Antunes 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[D-tryptophan] 1.30 1.00 5.0 25.0 UV electronic spectroscopy O. A. C. Antunes 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[L-tryptophan] -0.05 -0.70 5.0 25.0 UV electronic spectroscopy O. A. C. Antunes 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cannabidiol] 4.14 7.4 25.0 HPLC method Janne Mannila 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[∆9-tetrahydrocannabinol] 3.62 7.4 25.0 HPLC method Janne Mannila 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclosporin A] 2.30 7.0 25.0 HPLC method Laura Matilainen 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclosporin A] 1.34 25.0 HPLC-method Yingqing Ran 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-xylene] 2.51 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-xylene] 2.27 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[heptane] 1.60 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](0.5).[heptane] 3.38 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](0.33).[heptane] 3.70 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[benzyl alcohol] 1.15 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](0.5).[benzyl alcohol] 0.70 7.0 25.0 Gas chromatography G.W. Meindersma 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[gliquidone] 2.60 7.0 25.0 UV-vis spectroscopy M.I. La Rotonda 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[gliquidone] 2.54 1.5 25.0 UV-vis spectroscopy M.I. La Rotonda 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[gliquidone] 3.12 4.5 25.0 UV-vis spectroscopy M.I. La Rotonda 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[gliquidone] 3.26 7.4 25.0 UV-vis spectroscopy M.I. La Rotonda 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Dns-L-Phe] 2.07 Capillary electrophoresis Bezhan Chankvetadze 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Dns-D-Phe] 2.17 Capillary electrophoresis Bezhan Chankvetadze 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Dns-L-Trp] 1.97 Capillary electrophoresis Bezhan Chankvetadze 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Dns-D-Trp] 1.49 Capillary electrophoresis Bezhan Chankvetadze 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Dns-L-Val] 1.75 Capillary electrophoresis Bezhan Chankvetadze 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Dns-D-Val] 1.75 Capillary electrophoresis Bezhan Chankvetadze 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[celecoxib] 2.95 7.0 30.0 UV-vis spectroscopy M. S. Nagarsenker 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[celecoxib] 2.28 7.0 25.0 HPLC, NMR spectroscopy Cinzia AnnaVentura 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nimesulide] 2.27 0.55 7.0 28.0 UV-vis spectroscopy Buchi N. Nalluri 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nimesulide] 3.11 7.7 25.0 HPLC-method Eric Peyrin 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nimesulide] 3.06 7.7 30.0 HPLC-method Eric Peyrin 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nimesulide] 3.04 7.7 35.0 HPLC-method Eric Peyrin 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nimesulide] 3.03 7.7 40.0 HPLC-method Eric Peyrin 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[meloxicam] 2.23 0.69 7.0 28.0 UV-vis spectroscopy Buchi N. Nalluri 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[b-lapachone] 2.97 1.90 7.4 25.0 UV-vis spectroscopy Jinming Gao 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[b-lapachone] 3.03 1.78 7.4 25.0 Fluorescence spectroscopy Jinming Gao 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[b-lapachone] 2.82 1.43 7.0 25.0 NMR spectroscopy Jinming Gao 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[1-{[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d] pyrimidin-5-yl)-4-ethoxyphenyl] sulfonyl}-4-methylpiperazine] 1.83 0.60 8.7 30.0 UV-vis spectroscopy Mahmoud M. Al Omari 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[valdecoxib] 2.48 6.8 25.0 UV-vis spectroscopy Tayade Pralhad 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[cyclosporin A] 0.78 25.0 HPLC-method Yingqing Ran 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[sertaconazole] 2.73 1.2 25.0 UV-vis spectroscopy Juan J. Torres-Labandeira 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[sertaconazole] 1.58 5.8 25.0 UV-vis spectroscopy Juan J. Torres-Labandeira 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[sertaconazole] 0.91 7.4 25.0 UV-vis spectroscopy Juan J. Torres-Labandeira 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[sertaconazole] 0.76 1.2 25.0 UV-vis spectroscopy Juan J. Torres-Labandeira 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[sertaconazole] 1.80 7.4 25.0 UV-vis spectroscopy Juan J. Torres-Labandeira 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[sertaconazole] -1.70 5.8 25.0 UV-vis spectroscopy Juan J. Torres-Labandeira 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[tolfenamic acid] 2.68 7.0 25.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[tolfenamic acid] 2.35 7.0 30.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[tolfenamic acid] 2.04 7.0 37.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[tolfenamic acid] 1.72 7.0 45.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprofen] 3.17 13.0 30.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprofen] 3.11 14.0 37.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprofen] 2.74 15.0 45.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprofen] 2.39 16.0 52.0 HPLC-method E. Antoniadou-Vyza 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprofen] 2.83 3.0 32.0 HPLC-method Prakash Vaman Rao Diwan 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoprofen] 2.11 6.0 32.0 HPLC-method Prakash Vaman Rao Diwan 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenylbenzimidazole sulphonic acid] 1.90 0.40 4.0 25.0 HPLC-method Santo Scalia 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-(Methylthio)phenol] 2.56 1.70 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[4-(Methylthio)phenol] 2.18 1.60 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-(Methylthio)toluene] 2.26 1.48 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[4-(Methylthio)toluene] 2.20 1.70 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-(methylthio)phenylmethanol] 2.30 1.48 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[4-(methylthio)phenylmethanol] 2.11 1.60 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-(Methylthio)phenylacetic acid] 2.51 1.60 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[4-(Methylthio)phenylacetic acid] 2.08 1.60 2.0 25.0 UV-vis spectroscopy Tetsuro Majima 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoconazole] 3.81 2.48 6.0 25.0 UV-vis spectroscopy Joanna Taraszewska 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoconazole] 3.93 2.60 6.0 20.0 UV-vis spectroscopy Joanna Taraszewska 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoconazole] 3.57 2.48 6.0 35.0 UV-vis spectroscopy Joanna Taraszewska 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ketoconazole] 3.41 2.48 6.0 45.0 UV-vis spectroscopy Joanna Taraszewska 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[naftifine] 2.92 1.34 12.0 25.0 UV-vis spectroscopy Itziar Velaz 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[(S)-6-methoxy-b-methyl-2-naphthalene acetic acid] 3.81 2.60 9.0 25.0 Fluorescence spectroscopy E. Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[(S)-6-methoxy-b-methyl-2-naphthalene acetic acid] 3.15 1.90 1.0 25.0 Fluorescence spectroscopy E. Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 3.95 1.60 7.4 5.0 Ion selective electrode potentiometry P.E. Macheras 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 3.92 1.60 7.4 15.0 Ion selective electrode potentiometry P.E. Macheras 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 3.75 1.60 7.4 25.0 Ion selective electrode potentiometry P.E. Macheras 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-(2,4-difluorophenylsalicylic) acid] 3.74 1.78 7.4 37.0 Ion selective electrode potentiometry P.E. Macheras 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-nitrophenol] 1.94 7.0 25.0 HPLC-method Michel Morcellet 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[iodine] 1.58 7.0 25.0 Sodium thiosulfate titration Lajos Szente 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flutamide] 2.50 7.0 25.0 UV-vis spectroscopy Leonard I. Wiebe 2000
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flutamide] 2.53 7.0 30.0 UV-vis spectroscopy Leonard I. Wiebe 2000
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flutamide] 2.59 7.0 37.0 UV-vis spectroscopy Leonard I. Wiebe 2000
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flutamide] 2.65 7.0 45.0 UV-vis spectroscopy Leonard I. Wiebe 2000
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flutamide] 2.66 7.0 50.0 UV-vis spectroscopy Leonard I. Wiebe 2000
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-nitrophenol] 2.26 7.0 25.0 HPLC-method Michel Morcellet 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[tetratosylate salt of 5,10,15,20-tetrakis(4-N-methylpyridyl) porphyrin] 3.73 2.70 7.0 25.0 Fluorescence spectroscopy Kamil Lang 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-cresol] 2.08 7.0 25.0 HPLC-method Michel Morcellet 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-amino-N-[5-methyl-1,3,4-thiadiazol-2-yl]-benzenesulphonamide] 2.75 7.0 37.0 UV-vis spectroscopy Juan J. Torres-Labandeira 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nimodipine] 2.66 1.63 7.0 25.0 UV-vis spectroscopy Frantisek Kopecky 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[beclomethasone] 2.68 HPLC-method Nicholas H. Snow 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-nitrophenyl-phthalamic acid] 1.95 1.30 2.0 25.0 UV-vis spectroscopy Rita H. de Rossi 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[phenyl-phthalamic acid] 1.57 0.48 2.0 25.0 UV-vis spectroscopy Rita H. de Rossi 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[adamantyl-phthalamic acid] 4.61 3.78 10.47 25.0 UV-vis spectroscopy Rita H. de Rossi 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[N-phenyl maleamic acid] 1.69 0.48 2.0 25.0 UV-vis spectroscopy Rita H. de Rossi 2001
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-cresol] 2.45 7.0 25.0 HPLC-method Michel Morcellet 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nicardipine] 1.19 -0.82 7.0 UV-vis spectroscopy Francisco J. B. Veiga 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nicardipine] 1.15 -0.31 3.0 UV-vis spectroscopy Francisco J. B. Veiga 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nicardipine] 1.47 0.06 5.5 UV-vis spectroscopy Francisco J. B. Veiga 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[nicardipine] 1.84 0.64 7.4 UV-vis spectroscopy Francisco J. B. Veiga 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[glycine isoindole] 1.64 7.0 Fluorescence spectroscopy Brian D. Wagner 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[lysine isoindole] 2.11 7.0 Fluorescence spectroscopy Brian D. Wagner 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[harmane] 2.62 1.48 7.8 22.0 Fluorescence spectroscopy B. del Castillo 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[harmine] 2.46 0.85 7.8 22.0 Fluorescence spectroscopy B. del Castillo 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[vinpocetine] 1.54 7.0 22.0 UV-vis spectroscopy Laura Ribeiro 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[carprofen] 2.69 7.0 25.0 UV-vis spectroscopy Chen, Fu-An 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-amino-1,8-naphthalimide] 2.03 2.0 25.0 Fluorescence spectroscopy Sergio Brochsztain 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-amino-1,8-naphthalimide] 2.29 7.0 25.0 Fluorescence spectroscopy Sergio Brochsztain 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-(2-phosphonoethylamino)-N-(2-phosphonoethyl)-1,8-naphthalimide, tetraethylester] 2.19 2.0 25.0 Fluorescence spectroscopy Sergio Brochsztain 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-(2-phosphonoethylamino)-N-(2-phosphonoethyl)-1,8-naphthalimide, tetraethylester] 2.08 7.0 25.0 Fluorescence spectroscopy Sergio Brochsztain 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2,4,6-trichlorophenol] 2.41 3.0 24.0 UV-vis spectroscopy K. Hanna 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2,4,6-trichlorophenol] 1.18 8.8 24.0 UV-vis spectroscopy K. Hanna 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[amantadine] 2.34 7.0 24.5 Capillary electrophoresis Sam Fong Yau Li 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[9-methyl-12H-benzo[a]phenotiazine] 2.66 2.00 7.0 20.0 Fluorescence spectroscopy Jean-Jacques Aaron 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[diflunisal] 3.59 2.56 7.4 24.0 Equilibrium dialysis method-HPLC method James Blanchard 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[diflunisal] 3.53 7.4 25.0 Microcalorimetric titrations James Blanchard 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-tridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt] 3.35 7.0 25.0 NMR spectroscopy Kaneto Uekama 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyl-tridecyl)-2H-1-benzopyran-6-yl-hydrogen phosphate] potassium salt] 2.54 7.0 25.0 NMR spectroscopy Kaneto Uekama 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3,3',4',5',7-pentahydroxy flavone] 2.73 7.0 25.0 UV-vis spectroscopy Tayade Pralhad 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[b-ionone] 6.70 7.0 NMR spectroscopy N.E. Polyakov 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[(+)-6-methoxy-α-methyl-2-naphthalene-acetic sodium salt] 3.03 0.60 7.0 25.0 Fluorescence spectroscopy Margarita Valero 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[naringenin] 2.92 4.0 25.0 UV-vis spectroscopy M. L. Calabro 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[naringenin] 1.65 8.0 25.0 UV-vis spectroscopy M. L. Calabro 2004
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-nitrophenolate] 2.82 2.00 11.1 27.8 Capillary electrophoresis David M. Goodall 1995
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[methyl tert-butyl ether] 2.35 25.0 GC Ji-Won Yang 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-hexane] 1.00 0.67 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-heptane] 1.63 2.06 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-octane] 1.70 0.78 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-nonane] 1.88 0.70 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-decane] 1.94 0.85 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-undecane] 1.80 1.18 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-dodecane] 1.52 0.95 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclohexane] 2.56 1.69 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Me-cyclohexane] 2.40 0.30 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Et-cyclohexane] 2.80 2.11 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-xylene] 2.22 1.11 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-xylene] 2.37 1.20 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Et-benzene] 2.39 1.58 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[1,3,5-trimethyl-benzene] 1.70 1.11 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[1,2,3-trimethyl-benzene] 2.29 1.46 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[1,2,4-trimethyl-benzene] 2.33 1.15 25.0 GC (SHSGC) É. Fenyvesi 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[meso-tetrakis(4-N-ethylpyridiumyl) porphyrin] 4.04 7.61 20.0 UV-vis and fluorescence spectroscopy Shuang Shaomin 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[meso-tetrakis(4-N-methylpyridiumyl) porphyrin] 5.05 7.61 20.0 UV-vis and fluorescence spectroscopy Shuang Shaomin 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin].[poly(N-isopropylacrylamide)] 3.00 23.0 Surface plasmon resonance Véronique Wintgens 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[T-3912] 3.98 7.5 25.0 HPLC Tetsumi Yamakawa 2003
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[fenoxaprop-p-ethyl] 2.77 6.0 25.0 differential scanning calorimetry, infrared spectroscopy, X-ray diffraction Weiping Liu 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dodecyltrimethylammonium bromide] 3.46 2.88 25.0 computerized electrical conductivity technique Emilio Aicart 1995
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[riboflavin] 3.52 2.32 UV, NMR and fluorescence spectroscopy Gregory Gregoriadis 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[alkannin/shikonin enantiomers] 2.42 6.7 25.0 spectrophotometry Hui-Wen Cheng 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[alkannin/shikonin enantiomers] 1.19 9.0 HPLC Hui-Wen Cheng 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[bupivacaine] 1.98 -0.10 25.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[bupivacaine] 2.01 -0.40 37.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[etidocaine] 1.38 -0.10 25.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[etidocaine] 1.31 -0.52 37.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[lidocaine] 1.30 -0.52 25.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[lidocaine] 1.36 -0.40 37.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[mepivacaine] 1.58 0.04 25.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[mepivacaine] 1.62 0.11 37.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[prilocaine] 1.48 -0.70 25.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[prilocaine] 1.46 0.08 37.0 HPLC Gilles Dollo 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[arachidonylethanolamide] 4.60 7.4 25.0 HPLC Pekka Jarho 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[arachidonylethanolamide] 1.08 7.4 25.0 HPLC Pekka Jarho 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-phenoxypropionic acid; enantiomer 2] 1.49 0.40 7.0 23.0 capillary electrophoresis Daniel W. Armstrong 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-(4-chlorophenoxy)propionic acid; enantiomer 2] 2.18 1.18 7.0 23.0 capillary electrophoresis Daniel W. Armstrong 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[methocarbamol] 1.25 28.0 HPLC, NMR spectroscopy Ekaterini Antoniadou-Vyza 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-hydroxy-N-(5-methyl-3-isoxazolyl)-1,4-naphtoquinone-4-imine] 2.60 1.08 25.0 UV spectroscopy Marcela Longhi 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-hydroxy-N-(5-methyl-3-isoxazolyl)-1,4-naphtoquinone-4-imine anion] 2.05 0.95 25.0 UV spectroscopy Marcela Longhi 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[haloperidol] 3.32 7.0 27.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[haloperidol] 3.05 7.0 37.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[haloperidol] 2.91 7.0 47.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[haloperidol] 2.72 7.0 57.0 UV-vis spectroscopy, NMR, differential scanning calorimetry Gregory Gregoriadis 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[salicylic acid] 3.09 2.26 1.0 25.0 fluorescence emission spectroscopy Emilio Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[salicylic acid] 2.39 1.57 7.0 25.0 fluorescence emission spectroscopy Emilio Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[salicylic acid] 3.20 2.0 25.0 fluorescence emission spectroscopy Emilio Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[salicylic acid] 1.77 4.0 25.0 fluorescence emission spectroscopy Emilio Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[salicylate] 2.38 1.54 1.0 25.0 fluorescence emission spectroscopy Emilio Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[clofibrate] 2.91 25.0 NMR spectroscopy S. Anguiano-Igea 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[11-methyl-12H-benzo(a)phenothiazine] 2.07 0.48 20.0 fluorescence spectroscopy Jean-Jacques Aaron 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-nor-pregn-4-ene-3,20-dione] 2.97 7.4 65.0 HPLC Sayed M. Ahmed 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-nor-pregn-4-ene-3,20-dione] 3.45 2.44 30.0 Sayed M. Ahmed 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-nor-pregn-4-ene-3,20-dione] 3.36 2.18 37.0 Sayed M. Ahmed 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-nor-pregn-4-ene-3,20-dione] 3.05 1.56 45.0 Sayed M. Ahmed 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[16-methylene-17a-acetoxy-19-nor-pregn-4-ene-3,20-dione] 2.97 HPLC Sayed M. Ahmed 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dodecylethyldimethylammonium bromide] 0.18 25.0 fluorescence spectroscopy Emilio Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[dodecylethyldimethylammonium ion] 3.51 2.90 25.0 fluorescence spectroscopy Emilio Aicart 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophen] 4.16 3.18 15.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophen] 4.05 3.04 20.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophen] 3.98 3.00 25.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophen] 3.83 2.85 30.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophen] 3.73 2.70 35.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophen] 3.65 2.60 40.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophenate ion] 3.60 2.60 15.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophenate ion] 3.49 2.48 20.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophenate ion] 3.40 2.40 25.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophenate ion] 3.24 2.23 30.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophenate ion] 3.18 2.18 35.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[flurbiprophenate ion] 3.07 2.08 40.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophen] 4.23 3.23 15.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophen] 4.19 3.18 20.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophen] 4.20 3.20 25.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophen] 4.12 3.11 30.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophen] 4.02 3.00 35.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophen] 3.94 2.95 40.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophenate ion] 3.64 2.60 15.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophenate ion] 3.66 2.70 20.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophenate ion] 3.67 2.70 25.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophenate ion] 3.65 2.70 30.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophenate ion] 3.49 2.48 35.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ibuprophenate ion] 3.41 2.41 40.0 pH potentiometry Emilio Aicart 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[unsubstitued benzo(a)phenothiazine] 2.00 1.30 fluorescence spectroscopy Jean-Jacques Aaron 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[10-methyl-12H-benzo(a)phenothiazine] 1.70 1.04 20.0 fluorescence spectroscopy Jean-Jacques Aaron 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[coumatetralyl] 2.79 1.59 20.0 fluorescence spectroscopy Jean-Jacques Aaron 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[pirimiphos-methyl] 2.87 1.77 10.0 20.0 fluorescence spectroscopy Jean-Jacques Aaron 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[chlorpyriphos] 2.06 1.28 4.0 20.0 fluorescence spectroscopy, photochemically induced fluorescence method Jean-Jacques Aaron 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[deltamethrin] 2.92 2.09 11.0 20.0 fluorescence spectroscopy, photochemically induced fluorescence method Jean-Jacques Aaron 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[fenvalerate] 2.18 1.66 10.0 20.0 fluorescence spectroscopy, photochemically induced fluorescence method Jean-Jacques Aaron 1998
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ricobendazole] 2.49 25.0 HPLC Natalie J. Medlicott 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ricobendazole] 2.14 differential scanning calorimetry Natalie J. Medlicott 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[albendazole] 4.26 Natalie J. Medlicott 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[albendazole] 2.31 differential scanning calorimetry Natalie J. Medlicott 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoic acid] 2.99 2.00 15.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoic acid] 2.95 1.95 20.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoic acid] 2.87 1.85 25.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoic acid] 2.86 1.85 30.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoic acid] 2.64 1.70 40.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoic acid] 3.08 25.0 Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoate] 2.15 1.48 15.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoate] 2.04 1.30 20.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoate] 1.95 1.30 25.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoate] 1.85 1.18 30.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoate] 1.57 0.90 40.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[o-hydroxybenzoate] 2.34 25.0 Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-hydroxybenzoic acid] 2.86 1.85 15.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-hydroxybenzoic acid] 2.79 1.78 20.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-hydroxybenzoic acid] 2.72 1.70 25.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-hydroxybenzoic acid] 2.65 1.60 30.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-hydroxybenzoic acid] 2.48 1.48 40.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[m-hydroxybenzoate] 0.70 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid] 3.04 2.04 15.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid] 2.97 1.95 20.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid] 2.94 1.95 25.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid] 2.86 1.85 30.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoic acid] 2.72 1.70 40.0 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[p-hydroxybenzoate] 0.70 pH Potentiometry Emilio Aicart 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[ethyl alcohol] -0.32 -1.30 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-propyl alcohol] 0.50 -1.15 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-propyl alcohol] 0.76 -0.22 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-butyl alcohol] 1.19 -0.62 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-pentyl alcohol] 1.78 0.60 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-pentyl alcohol] 1.80 0.30 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-hexyl alcohol] 2.36 0.83 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-hexyl alcohol] 2.27 0.53 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-heptil alcohol] 2.82 1.76 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[isopropyl alcohol] 0.55 -0.68 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[isopropyl alcohol] 0.59 -0.55 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[isobutyl alcohol] 1.39 0.40 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[isopentyl alcohol] 2.03 0.74 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-butyl alcohol] 1.08 -0.40 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-pentyl alcohol] 1.38 0.13 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-hexyl alcohol] 1.88 0.90 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-pentyl alcohol] 1.49 -0.24 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[tert-butyl alcohol] 1.40 0.14 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[neopentyl alcohol] 2.54 1.34 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclopentyl alcohol] 1.97 0.90 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclohexyl alcohol] 2.66 0.92 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclohexyl alcohol] 2.44 1.23 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[2-methoxy etylalcohol (MeOCH2CH2OH)] -0.08 -1.40 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Butyl sulfit ion (BuSO3-)] 0.98 -1.00 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Pentyl sulfit ion (PentSO3-)] 1.58 0.19 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Hexyl sulfit ion (HexSO3-)] 2.02 0.40 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Heptyl sulfit ion (HeptSO3-)] 2.47 1.37 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[Octyl sulfit ion (OctSO3-)] 2.97 2.06 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[1-anilino-8-naphthalenesulfonate ion] 2.77 1.14 11.6 25.0 spectrofluorometry Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-propylamine] 0.85 -0.70 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-butylamine] 1.37 0.09 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-pentylamine] 1.86 0.63 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-hexylamine] 2.32 1.19 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-heptylamine] 2.88 1.46 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-dimethyl-hexalamine] 2.44 1.43 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclopentylamine] 1.79 0.54 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclohexylamine] 2.28 0.98 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[HO(CH2)3NH2] 0.25 -1.52 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[n-octylamine] 3.28 1.93 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[piperidine] 1.71 0.57 11.6 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[prednisolone] 3.39 1.75 5.5 25.0 NMR spectroscopy Kim L.Larsen 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[prednisolone] 3.12 25.0 UV-vis spectroscopy Kim L.Larsen 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[6a-methyl prednisolone] 2.76 1.20 5.5 25.0 NMR spectroscopy Kim L.Larsen 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[6a-methyl prednisolone] 2.75 25.0 UV-vis spectroscopy Kim L.Larsen 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[6a-methyl prednisolone] 2.79 25.0 Kim L.Larsen 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[itraconazole] 3.72 2.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[itraconazole] 1.18 4.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[itraconazole] 3.28 7.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[itraconazole] 1.58 2.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[itraconazole] 3.40 4.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](2).[itraconazole] 0.00 7.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](3).[itraconazole] 1.08 4.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](3).[itraconazole] 2.42 7.0 25.0 UV spectroscopy, HPLC Marcus E. Brewster 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[acetone] 0.38 -1.24 11.6 25.0 inhibition kinetics method Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[butan-2-one] 0.89 -0.37 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[butan-2-one] 0.95 -0.39 8.0 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[pentan-2-one] 1.25 0.20 8.0 25.0 displacement of a fluorescent probe Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hexan-2-one] 1.73 0.66 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[heptan-2-one] 2.18 -0.16 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[octan-2-one] 2.71 1.67 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[pentan-3-one] 1.14 -0.05 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hexan-3-one] 1.56 0.24 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[heptan-3-one] 1.93 0.47 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[octan-3-one] 2.22 1.22 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclobutanone] 1.10 -0.08 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclopentanone] 1.49 0.51 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclohexanone] 2.23 1.26 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cycloheptanone] 2.71 1.74 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[cyclooctanone] 3.03 2.17 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-methylbutan-2-one] 1.65 0.67 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3-methylpentan-2-one] 2.00 0.61 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[5-methylhexan-2-one] 2.43 1.34 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[3,3-dimethylbutan-2-one] 2.40 1.47 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[4-methylpentan-2-one] 1.82 0.51 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[heptan-4-one] 1.96 0.04 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[acetophenone] 2.15 0.63 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[heptan-2-ol] 2.52 1.39 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[hexan-3-ol] 1.68 0.57 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[heptan-3-ol] 2.19 0.97 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[octan-3-ol] 2.85 1.85 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[1-phenylethanol] 2.19 0.87 11.6 25.0 inhibition kinetics method, stopped-flow spectroscopy Oswald S.Tee 1996
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[gentian violet] 2.26 1.48 7.5 25.0 UV-vis spectroscopy David Díaz 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[gentian violet] 2.04 1.00 25.0 UV-vis spectroscopy David Díaz 1999
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[6-p-toluidinylnaphthalene-2-sulfonate] 3.17 1.88 25.0 Uv-vis spectrophotometry Yannis L. Loukas 2002

2-O-(2-Hydroxy)propyl-g-Cyclodextrin
MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
None None CY-3005.0 None

SMILES:

Supramolecules

Namelog KSDpHT(°C)MethodRef
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin].[7-methoxycoumarin] 1.62 0.78 fluorescence suppression Wagner, Brian D. 2003
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[Cyproterone acetate] 3.66 25.0 phase solubility Sandrine Henry De Hassonville 2002
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](2).[Cyproterone acetate] 0.85 25.0 phase solubility Sandrine Henry De Hassonville 2002
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[spironolactone] 3.85 phase solubility Kaneto Uekama 1997
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[rose bengal] 2.28 1.48 7.0 25.0 UV-Vis spectroscopy P. Fini 2004
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[rose bengal] 2.32 1.30 7.0 25.0 Calorimetry P. Fini 2004
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[Fe(III)-tetrakis(sulfonatophenyl)porphyrin] 1.89 0.06 6.0 25.0 UV-Vis spectroscopy Masami Fukushima 2006
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[tetrakis(sulfonatophenyl)porphyrin] 2.23 0.14 6.0 25.0 UV-Vis spectroscopy Masami Fukushima 2006
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[tetratosylate salt of 5,10,15,20-tetrakis(4-N-methylpyridyl) porphyrin] 2.79 2.08 7.0 25.0 Fluorescence spectroscopy Kamil Lang 2001
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[nimodipine] 1.72 1.18 7.0 25.0 UV-vis spectroscopy Frantisek Kopecky 2001
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[4-(2-phosphonoethylamino)-N-(2-phosphonoethyl)-1,8-naphthalimide, tetraethylester] 2.48 7.0 25.0 Fluorescence spectroscopy Sergio Brochsztain 2002
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[b-ionone] 4.00 7.0 NMR spectroscopy N.E. Polyakov 2004
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[triclosan] 3.60 7.0 25.0 UV-vis spectroscopy P. Mura 2005
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[({2-[4-(4,6-diamino-[1,3,5]triazin-2-ylamino)-phenyl]-[1,3,2]dithiarsolan-4-yl}-methanol] 4.71 3.71 7.0 25.0 HPLC-method Stephane Gibaud 2005
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[({2-[4-(4,6-diamino-[1,3,5]triazin-2-ylamino)-phenyl]-[1,3,2]dithiarsolan-4-yl}-methanol] 4.73 3.73 7.0 25.0 UV-vis spectroscopy Stephane Gibaud 2005
[2-O-(2-Hydroxy)propyl-g-Cyclodextrin](1).[arachidonylethanolamide] 4.19 7.4 25.0 HPLC Pekka Jarho 1996